Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 2, 2018
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
Thu, March 1, 2018
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
Ralph Giacobbe Maintained (THC) at Strong Buy with Increased Target to $27 on, Mar 1st, 2018
Ralph Giacobbe of Citigroup, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Increased Target from $19 to $27 on, Mar 1st, 2018.
Ralph has made no other calls on THC in the last 4 months.
There are 5 other peers that have a rating on THC. Out of the 5 peers that are also analyzing THC, 2 agree with Ralph's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gary Lieberman of "Wells Fargo" Maintained at Hold with Increased Target to $22 on, Wednesday, February 28th, 2018
- Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017
These are the ratings of the 3 analyists that currently disagree with Ralph
- Andrew Schenker of "Morgan Stanley" Maintained at Sell with Increased Target to $16 on, Wednesday, February 28th, 2018
- John Ransom of "Raymond James" Upgraded from Hold to Buy on, Wednesday, February 28th, 2018
- Gary Taylor of "JP Morgan" Downgraded from Hold to Sell on, Thursday, December 14th, 2017
